FINGERMOTION INC (FNGR)

US31788K1088 - Common Stock

1.14  -0.04 (-3.39%)

After market: 1.15 +0.01 (+0.88%)

Fundamental Rating

3

Taking everything into account, FNGR scores 3 out of 10 in our fundamental rating. FNGR was compared to 22 industry peers in the Wireless Telecommunication Services industry. The financial health of FNGR is average, but there are quite some concerns on its profitability. FNGR is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

In the past year FNGR has reported negative net income.
FNGR had a negative operating cash flow in the past year.
FNGR had negative earnings in each of the past 5 years.
In the past 5 years FNGR always reported negative operating cash flow.

1.2 Ratios

FNGR has a Return On Assets of -18.89%. This is amonst the worse of the industry: FNGR underperforms 80.95% of its industry peers.
FNGR's Return On Equity of -57.46% is on the low side compared to the rest of the industry. FNGR is outperformed by 80.95% of its industry peers.
Industry RankSector Rank
ROA -18.89%
ROE -57.46%
ROIC N/A
ROA(3y)-36.86%
ROA(5y)-44.25%
ROE(3y)-62.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

FNGR has a Gross Margin of 7.51%. This is amonst the worse of the industry: FNGR underperforms 90.48% of its industry peers.
FNGR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for FNGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.94%
GM growth 5Y-14.14%

6

2. Health

2.1 Basic Checks

FNGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FNGR has more shares outstanding
Compared to 5 years ago, FNGR has more shares outstanding
There is no outstanding debt for FNGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

FNGR has an Altman-Z score of 1.24. This is a bad value and indicates that FNGR is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.24, FNGR is doing good in the industry, outperforming 61.90% of the companies in the same industry.
There is no outstanding debt for FNGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC9.18%

2.3 Liquidity

A Current Ratio of 1.48 indicates that FNGR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.48, FNGR is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
FNGR has a Quick Ratio of 1.48. This is a normal value and indicates that FNGR is financially healthy and should not expect problems in meeting its short term obligations.
FNGR's Quick ratio of 1.48 is amongst the best of the industry. FNGR outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48

3

3. Growth

3.1 Past

FNGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.69%, which is quite good.
Looking at the last year, FNGR shows a very negative growth in Revenue. The Revenue has decreased by -31.72% in the last year.
FNGR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 89.36% yearly.
EPS 1Y (TTM)9.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-31.72%
Revenue growth 3Y28.98%
Revenue growth 5Y89.36%
Sales Q2Q%-8.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y143.71%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year69.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FNGR. In the last year negative earnings were reported.
FNGR is valuated quite expensively with a Price/Forward Earnings ratio of 37.25.
Based on the Price/Forward Earnings ratio, FNGR is valued a bit more expensive than the industry average as 76.19% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 23.61. FNGR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 37.25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

FNGR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FNGR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FINGERMOTION INC

NASDAQ:FNGR (1/8/2025, 8:02:29 PM)

After market: 1.15 +0.01 (+0.88%)

1.14

-0.04 (-3.39%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)10-23 2024-10-23
Earnings (Next)01-21 2025-01-21
Inst Owners2.99%
Inst Owner Change0%
Ins Owners6.67%
Ins Owner Change0%
Market Cap65.14M
Analysts82.86
Price Target5.1 (347.37%)
Short Float %3.54%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.25
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 6.56
P/tB 6.58
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.03
Fwd EY2.68%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.55
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.89%
ROE -57.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.51%
FCFM N/A
ROA(3y)-36.86%
ROA(5y)-44.25%
ROE(3y)-62.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.94%
GM growth 5Y-14.14%
F-Score2
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.88%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 1.24
F-Score2
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)55.73%
Cap/Depr(5y)233.44%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y143.71%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.72%
Revenue growth 3Y28.98%
Revenue growth 5Y89.36%
Sales Q2Q%-8.84%
Revenue Next Year69.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.76%
OCF growth 3YN/A
OCF growth 5YN/A